Artal Group as of Dec. 31, 2018
Portfolio Holdings for Artal Group
Artal Group holds 94 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Weight Watchers International | 21.2 | $571M | 15M | 38.55 | |
| Lexicon Pharmaceuticals (LXRX) | 14.8 | $400M | 60M | 6.64 | |
| General Motors Company (GM) | 4.3 | $117M | 3.5M | 33.45 | |
| Beigene (ONC) | 4.2 | $112M | 800k | 140.26 | |
| Bank of America Corporation (BAC) | 4.1 | $111M | 4.5M | 24.64 | |
| Moderna (MRNA) | 3.0 | $80M | 5.3M | 15.27 | |
| Wells Fargo & Company (WFC) | 2.6 | $69M | 1.5M | 46.08 | |
| Celgene Corporation | 2.4 | $64M | 1.0M | 64.09 | |
| Morgan Stanley (MS) | 2.2 | $60M | 1.5M | 39.65 | |
| Alnylam Pharmaceuticals (ALNY) | 2.2 | $58M | 800k | 72.91 | |
| Alibaba Group Holding (BABA) | 2.1 | $57M | 412k | 137.07 | |
| Acceleron Pharma | 2.0 | $54M | 1.3M | 43.55 | |
| Scholar Rock Hldg Corp (SRRK) | 1.9 | $53M | 2.3M | 22.97 | |
| Rubius Therapeutics | 1.7 | $47M | 2.9M | 16.08 | |
| Nio Inc spon ads (NIO) | 1.6 | $42M | 6.6M | 6.37 | |
| Goldman Sachs (GS) | 1.6 | $42M | 250k | 167.05 | |
| Array BioPharma | 1.3 | $36M | 2.5M | 14.25 | |
| Atara Biotherapeutics | 1.3 | $35M | 1.0M | 34.74 | |
| Amicus Therapeutics (FOLD) | 1.2 | $34M | 3.5M | 9.58 | |
| Nektar Therapeutics | 1.2 | $33M | 1.0M | 32.87 | |
| Blueprint Medicines (BPMC) | 1.2 | $32M | 600k | 53.91 | |
| Bristol Myers Squibb (BMY) | 1.1 | $29M | 550k | 51.98 | |
| Agios Pharmaceuticals (AGIO) | 1.0 | $28M | 600k | 46.11 | |
| Fate Therapeutics (FATE) | 1.0 | $28M | 2.2M | 12.83 | |
| Bluebird Bio | 1.0 | $27M | 275k | 99.20 | |
| Argenx Se (ARGX) | 1.0 | $26M | 270k | 96.07 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.8 | $22M | 1.4M | 15.78 | |
| Fibrogen | 0.8 | $21M | 450k | 46.28 | |
| Freeport-McMoRan Copper & Gold (FCX) | 0.8 | $21M | 2.0M | 10.31 | |
| Medicines Company | 0.7 | $19M | 1.0M | 19.14 | |
| Xencor (XNCR) | 0.7 | $18M | 500k | 36.16 | |
| Inflarx Nv (IFRX) | 0.7 | $18M | 500k | 36.37 | |
| BioMarin Pharmaceutical (BMRN) | 0.6 | $17M | 200k | 85.15 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.6 | $16M | 475k | 32.84 | |
| Solid Biosciences | 0.5 | $13M | 500k | 26.80 | |
| Micron Technology (MU) | 0.5 | $13M | 400k | 31.73 | |
| Audentes Therapeutics | 0.5 | $13M | 600k | 21.32 | |
| Albireo Pharma | 0.5 | $12M | 500k | 24.53 | |
| Allogene Therapeutics (ALLO) | 0.4 | $11M | 400k | 26.93 | |
| Denali Therapeutics (DNLI) | 0.4 | $10M | 500k | 20.66 | |
| Wynn Resorts (WYNN) | 0.4 | $9.9M | 100k | 98.91 | |
| Clementia | 0.4 | $10M | 850k | 11.76 | |
| American Airls (AAL) | 0.4 | $9.6M | 300k | 32.11 | |
| Sage Therapeutics (SAGE) | 0.3 | $9.6M | 100k | 95.79 | |
| Anaptysbio Inc Common (ANAB) | 0.3 | $9.6M | 150k | 63.79 | |
| Melco Crown Entertainment (MLCO) | 0.3 | $8.8M | 500k | 17.62 | |
| Madrigal Pharmaceuticals (MDGL) | 0.3 | $7.9M | 70k | 112.71 | |
| Vici Pptys (VICI) | 0.3 | $7.5M | 400k | 18.78 | |
| Zogenix | 0.3 | $7.3M | 200k | 36.46 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $7.1M | 170k | 41.95 | |
| Ac Immune Sa (ACIU) | 0.3 | $7.1M | 750k | 9.45 | |
| Vale (VALE) | 0.2 | $6.6M | 500k | 13.19 | |
| Agenus | 0.2 | $6.5M | 2.8M | 2.38 | |
| Rocket Pharmaceuticals (RCKT) | 0.2 | $5.9M | 400k | 14.82 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.2 | $6.0M | 200k | 29.99 | |
| Accelr8 Technology | 0.2 | $5.8M | 500k | 11.50 | |
| Dicerna Pharmaceuticals | 0.2 | $5.6M | 525k | 10.69 | |
| Krystal Biotech (KRYS) | 0.2 | $5.7M | 275k | 20.78 | |
| Sangamo Biosciences (SGMO) | 0.2 | $4.6M | 400k | 11.48 | |
| Translate Bio | 0.2 | $4.5M | 600k | 7.50 | |
| Replimune Group (REPL) | 0.2 | $4.5M | 450k | 10.00 | |
| Iovance Biotherapeutics (IOVA) | 0.2 | $4.4M | 500k | 8.85 | |
| Cymabay Therapeutics | 0.1 | $3.9M | 500k | 7.87 | |
| Crispr Therapeutics (CRSP) | 0.1 | $4.1M | 145k | 28.57 | |
| D Stemline Therapeutics | 0.1 | $3.8M | 400k | 9.50 | |
| Spero Therapeutics (SPRO) | 0.1 | $3.7M | 600k | 6.15 | |
| Clovis Oncology | 0.1 | $3.6M | 200k | 17.96 | |
| Zafgen | 0.1 | $3.5M | 700k | 4.95 | |
| Restorbio | 0.1 | $3.4M | 400k | 8.62 | |
| Twist Bioscience Corp (TWST) | 0.1 | $3.5M | 150k | 23.09 | |
| Zillow Group Inc Cl C Cap Stk (Z) | 0.1 | $3.2M | 100k | 31.58 | |
| Arcus Biosciences Incorporated (RCUS) | 0.1 | $3.2M | 300k | 10.77 | |
| Merus N V (MRUS) | 0.1 | $2.9M | 206k | 14.00 | |
| Tricida | 0.1 | $2.9M | 125k | 23.58 | |
| Gritstone Oncology Ord (GRTSQ) | 0.1 | $3.1M | 200k | 15.45 | |
| Chimerix (CMRX) | 0.1 | $2.6M | 1.0M | 2.57 | |
| Akebia Therapeutics (AKBA) | 0.1 | $2.6M | 475k | 5.53 | |
| Aduro Biotech | 0.1 | $2.6M | 1.0M | 2.64 | |
| Aerpio Pharmaceuticals | 0.1 | $2.6M | 1.6M | 1.70 | |
| 111 Inc ads | 0.1 | $2.8M | 450k | 6.14 | |
| Momenta Pharmaceuticals | 0.1 | $2.2M | 200k | 11.04 | |
| Alder Biopharmaceuticals | 0.1 | $2.1M | 200k | 10.25 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $2.3M | 150k | 15.10 | |
| Homology Medicines | 0.1 | $2.2M | 100k | 22.36 | |
| Tg Therapeutics (TGTX) | 0.1 | $1.6M | 400k | 4.10 | |
| Selecta Biosciences | 0.1 | $1.6M | 600k | 2.66 | |
| Miragen Therapeutics | 0.1 | $1.5M | 500k | 3.03 | |
| Avrobio Ord (AVRO) | 0.1 | $1.7M | 100k | 16.65 | |
| Marinus Pharmaceuticals | 0.1 | $1.4M | 500k | 2.87 | |
| Ironwood Pharmaceuticals (IRWD) | 0.0 | $1.1M | 111k | 10.36 | |
| Magenta Therapeutics | 0.0 | $1.1M | 200k | 5.70 | |
| Y Mabs Therapeutics | 0.0 | $1.0M | 50k | 20.34 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $257k | 150k | 1.71 | |
| Noveliontherapeuti.. | 0.0 | $215k | 256k | 0.84 |
